Wilbanks Smith & Thomas Asset Management LLC Denali Therapeutics Inc. Transaction History

Wilbanks Smith & Thomas Asset Management LLC

  • $3.54 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022
SELL
$29.0 - $47.27 $156,049 - $254,359
-5,381 Closed
0 $0
Q3 2021

Nov 04, 2021
BUY
$48.48 - $78.23 $260,870 - $420,955
5,381 New
5,381 $271,000
Q4 2018

Feb 08, 2019
SELL
$13.88 - $21.75 $2,082 - $3,262
-150 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$12.46 - $21.74 $1,869 - $3,260
150 New
150 $3,000

Others Institutions Holding DNLI

# of Institutions
217
Shares Held
115M
Call Options Held
142K
Put Options Held
90.3K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.92B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Wilbanks Smith & Thomas Asset Management LLC Portfolio

Follow Wilbanks Smith & Thomas Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email